<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>https://ecency.com</link><image><url>https://ecency.com/logo512.png</url><title>RSS Feed</title><link>https://ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 15 Sep 2026 23:52:11 GMT</lastBuildDate><atom:link href="https://ecency.com/created/neurologicaldisorder/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Neurological Disorder Drugs Market Professional Survey Report 2018]]></title><description><![CDATA[This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Novartis AG GlaxoSmithKline plc Merck & Co. Bayer AG AstraZeneca]]></description><link>https://ecency.com/@jaydeep23/neurological-disorder-drugs-market-professional-survey-report-2018</link><guid isPermaLink="true">https://ecency.com/@jaydeep23/neurological-disorder-drugs-market-professional-survey-report-2018</guid><category><![CDATA[neurologicaldisorder]]></category><dc:creator><![CDATA[jaydeep23]]></dc:creator><pubDate>Sat, 16 Jun 2018 09:55:00 GMT</pubDate></item></channel></rss>